版本:
中国

BRIEF-Abeona gets orphan drug status for genetic skin disorder treatment

May 25 Abeona Therapeutics Inc

* Abeona Therapeutics receives FDA orphan drug designation for EB-101 gene therapy product for patients with epidermolysis bullosa Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐